Dr. Gerald Diaz @GeraldMD
23.1M 13.7K 7.2K
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief πŸ‡΅πŸ‡­ πŸ‡ΊπŸ‡Έ - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG: https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Contributor Ranks
Latest Searches
7 results
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
thrombosis in cancer ... patients at high risk ... also balance the risk ... #Algorithm #Anticoagulation ... #Management #Hematology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
Patient risk stratification ... algorithm for the treatment ... of cancer-associated ... #Algorithm #Anticoagulation ... #Management #Hematology
β–Ί
Hemophilia - Diagnosis and Management
Diagnosis:
 β€’ Consistent bleeding history (unless screening for disease in family members
center. ... Avoid meds that ... ↑ bleeding risk ... #Management #treatment ... #hematology
Irritable Bowel Syndrome (IBS) - Diagnosis and Management Summary
Diagnosis:
 β€’ Use a positive diagnostic strategy with
and Management ... cardiovascular risk ... and Hepatology ... #Management #gastroenterology ... #treatment
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 β€’ Isolated distal DVT (without cancer)
Thromboembolism Treatment ... at 3 Months β€’ Cancer ... Thromboembolism #Treatment ... #Algorithm #management ... #hematology #anticoagulation
Peripartum Cardiomyopathy - Summary
1. Definition
 β€’ Towards the end of pregnancy to 5 months postpartum
Differential Diagnosis ... suggest prophylactic anticoagulation ... teratogenic GDMT meds ... Cardiomyopathy #diagnosis ... #treatment
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
appropriate only for low risk ... patients with no CV risk ... Hydroxyurea + anticoagulation ... #diagnosis #management ... #hematology